MetaADEDB 2.0 @ LMMD
fludarabine phosphate
(GIUYCYHIANZCFB-FJFJXFQQSA-N)
Structure
SMILES
O[C@H]1[C@H](O)[C@H](O[C@H]1n1cnc2c1nc(F)nc2N)COP(=O)(O)O
Molecular Formula:
C10H13FN5O7P
Molecular Weight:
365.212
Log P:
-1.1427
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
5
TPSA:
195.88
CAS Number(s):
75607-67-9
Synonym(s)
1.
fludarabine phosphate
2.
9 beta-D-arabinofuranosyl-2-fluoroadenine monophosphate
3.
9H-purin-6-amine, 2-fluoro-9-(5-O-phosphono-beta-D-arabinofuranosyl)-
4.
Beneflur
5.
F-ara-AMP
6.
FaraAMP
7.
Fludara
8.
NSC 312887
9.
NSC-312887
10.
fludarabine 5'-monophosphate
11.
fludarabine monophosphate
12.
fluoro-ara-AMP
External Link(s)
MeSHC042382
PubChem Compound30751
BindingDB50248004
ChEBI63599
CHEMBLCHEMBL1096882
DrugCentral1189
KEGGdr:D01907
ZINC3927870
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AstheniaFAERS: 14US FAERS
2PneumoniaFAERS: 14US FAERS
3BlindnessFAERS: 13US FAERS
4PancytopeniaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
5DizzinessFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
6MYELODYSPLASTIC SYNDROMEFAERS: 12US FAERS
7Histiocytosis haematophagicFAERS: 11OFFSIDES
US FAERS
8NeutropeniaFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
9Posterior reversible encephalopathy syndromeFAERS: 10US FAERS
10White blood cell count decreasedFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
11Disseminated Intravascular CoagulationFAERS: 9OFFSIDES
US FAERS
12InfectionFAERS: 9OFFSIDES
US FAERS
13AscitesFAERS: 8OFFSIDES
US FAERS
14Mental status changesFAERS: 8OFFSIDES
US FAERS
15Metabolic acidosisFAERS: 8OFFSIDES
US FAERS
16SplenomegalyFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
17LymphadenopathyFAERS: 7US FAERS
18Plasmablastic lymphomaFAERS: 7US FAERS
19Basal cell carcinomaFAERS: 6US FAERS
20EncephalomyelitisFAERS: 6US FAERS
21HeadacheFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
22MalnutritionFAERS: 6US FAERS
23NauseaFAERS: 6OFFSIDES
US FAERS
24ShockFAERS: 6US FAERS
25Autoimmune neutropeniaFAERS: 5OFFSIDES
US FAERS
26Autoimmune thrombocytopeniaFAERS: 5OFFSIDES
US FAERS
27DiplegiaFAERS: 5US FAERS
28LymphopeniaFAERS: 5US FAERS
29Respiratory FailureFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
30SepsisFAERS: 5US FAERS
31ThrombocytopeniaFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
32jaundiceFAERS: 5US FAERS
33Disease ProgressionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
34Drug ineffectiveFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
35General physical health deteriorationFAERS: 4US FAERS
36HypersensitivityFAERS: 4US FAERS
37LeukopeniaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
38Malignant neoplasm progressionFAERS: 4OFFSIDES
US FAERS
39Post transplant distal limb syndromeFAERS: 4OFFSIDES
US FAERS
40Squamous cell carcinomaFAERS: 4US FAERS
41Type III immune complex mediated reactionFAERS: 4OFFSIDES
US FAERS
42Abdominal PainFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
43AgitationFAERS: 3US FAERS
44Blood lactate dehydrogenase increasedFAERS: 3OFFSIDES
US FAERS
45BronchospasmFAERS: 3US FAERS
46Cerebrovascular accidentFAERS: 3US FAERS
47Chest discomfortFAERS: 3US FAERS
48DeliriumFAERS: 3US FAERS
49Depressed Level of ConsciousnessFAERS: 3US FAERS
50Engraft failureFAERS: 3OFFSIDES
US FAERS
51Epstein-Barr virus associated lymphoproliferative disorderFAERS: 3OFFSIDES
US FAERS
52Febrile NeutropeniaFAERS: 3OFFSIDES
US FAERS
53LethargyFAERS: 3US FAERS
54Myocardial InfarctionFAERS: 3US FAERS
55MyopathyFAERS: 3US FAERS
56Neutrophil count decreasedFAERS: 3OFFSIDES
US FAERS
57ParaparesisFAERS: 3OFFSIDES
US FAERS
58ParesisFAERS: 3US FAERS
59PruritusFAERS: 3US FAERS
60Psychiatric symptomFAERS: 3US FAERS
61Pulmonary HypertensionFAERS: 3US FAERS
62Pulmonary toxicityFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
63Respiratory distressFAERS: 3US FAERS
64Rhodococcus infectionFAERS: 3US FAERS
65Septic ShockFAERS: 3OFFSIDES
US FAERS
66SinusitisFAERS: 3OFFSIDES
US FAERS
67SomnolenceFAERS: 3US FAERS
68Stem cell transplantFAERS: 3OFFSIDES
US FAERS
69StomatitisFAERS: 3US FAERS
70TremorFAERS: 3US FAERS
71VomitingFAERS: 3US FAERS
72Abdominal discomfortFAERS: 2US FAERS
73AgnosiaFAERS: 2US FAERS
74AgranulocytosisFAERS: 2US FAERS
75Alanine Aminotransferase IncreasedFAERS: 2US FAERS
76AngerFAERS: 2US FAERS
77AngioedemaFAERS: 2US FAERS
78AnorexiaFAERS: 2OFFSIDES
US FAERS
79AnxietyFAERS: 2US FAERS
80AphasiaFAERS: 2US FAERS
81Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
82AtaxiaFAERS: 2US FAERS
83Bilirubin conjugated increasedFAERS: 2US FAERS
84Blood alkaline phosphatase increasedFAERS: 2US FAERS
85Blood sodium decreasedFAERS: 2US FAERS
86CandidiasisFAERS: 2US FAERS
87Cardiac ArrestFAERS: 2US FAERS
88ChillsFAERS: 2US FAERS
89DemyelinationFAERS: 2OFFSIDES
US FAERS
90Depressed moodFAERS: 2US FAERS
91Drug exposure during pregnancyFAERS: 2US FAERS
92EpistaxisFAERS: 2US FAERS
93Epstein-Barr virus antigen positiveFAERS: 2OFFSIDES
US FAERS
94ErythemaFAERS: 2US FAERS
95Eye painFAERS: 2US FAERS
96FatigueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
97Gamma-Glutamyltransferase IncreasedFAERS: 2US FAERS
98HepatotoxicityFAERS: 2OFFSIDES
US FAERS
99HypoxiaFAERS: 2OFFSIDES
US FAERS
100IncontinenceFAERS: 2US FAERS
101IridocyclitisFAERS: 2OFFSIDES
US FAERS
102JC virus infectionFAERS: 2OFFSIDES
US FAERS
103JC virus test positiveFAERS: 2US FAERS
104Lupus-like syndromeFAERS: 2US FAERS
105Lymphocyte count decreasedFAERS: 2OFFSIDES
US FAERS
106Lymphoplasmacytoid lymphoma/immunocytomaFAERS: 2US FAERS
107MalaiseFAERS: 2US FAERS
108Malignant transformationFAERS: 2US FAERS
109Muscle SpasticityFAERS: 2US FAERS
110Musculoskeletal PainFAERS: 2US FAERS
111No adverse eventFAERS: 2US FAERS
112Optic NeuritisFAERS: 2OFFSIDES
US FAERS
113OsteomyelitisFAERS: 2US FAERS
114PetechiaeFAERS: 2US FAERS
115PneumonitisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
116Prostate cancer recurrentFAERS: 2OFFSIDES
US FAERS
117Treatment related secondary malignancyFAERS: 2OFFSIDES
US FAERS
118Urinary IncontinenceFAERS: 2US FAERS
119Accidental overdoseFAERS: 1US FAERS
120Acute respiratory failureFAERS: 1OFFSIDES
US FAERS
121AmnesiaFAERS: 1US FAERS
122ArthralgiaFAERS: 1US FAERS
123Aspartate aminotransferase decreasedFAERS: 1US FAERS
124Autoimmune thyroiditisFAERS: 1OFFSIDES
US FAERS
125B-cell unclassifiable lymphoma high gradeFAERS: 1OFFSIDES
US FAERS
126Blood creatinine increasedFAERS: 1US FAERS
127Blood glucose increasedFAERS: 1US FAERS
128Bone marrow depressionFAERS: 1OFFSIDES
US FAERS
129Bone painFAERS: 1US FAERS
130Bronchopulmonary AspergillosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
131CD4 Lymphocytes DecreasedFAERS: 1OFFSIDES
US FAERS
132Central Nervous System InfectionFAERS: 1OFFSIDES
US FAERS
133Central nervous system lesionFAERS: 1OFFSIDES
US FAERS
134Cerebral InfarctionFAERS: 1US FAERS
135Cerebral atrophyFAERS: 1OFFSIDES
US FAERS
136Cerebral disorderFAERS: 1OFFSIDES
US FAERS
137DeafnessFAERS: 1US FAERS
138DehydrationFAERS: 1US FAERS
139DementiaFAERS: 1US FAERS
140Dentofacial anomalyFAERS: 1US FAERS
141DiplopiaFAERS: 1US FAERS
142DisorientationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
143DiverticulitisFAERS: 1US FAERS
144Drug exposure before pregnancyFAERS: 1US FAERS
145DysarthriaFAERS: 1US FAERS
146DysgraphiaFAERS: 1US FAERS
147DysphasiaFAERS: 1US FAERS
148EncephalitisFAERS: 1OFFSIDES
US FAERS
149Engraftment syndromeFAERS: 1OFFSIDES
US FAERS
150EosinophiliaFAERS: 1US FAERS
151EpilepsyFAERS: 1US FAERS
152Erythema MultiformeFAERS: 1US FAERS
153Fanconi SyndromeFAERS: 1US FAERS
154FasciitisFAERS: 1US FAERS
155Feeling jitteryFAERS: 1US FAERS
156Fluid overloadFAERS: 1US FAERS
157FolliculitisFAERS: 1US FAERS
158Full blood count decreasedFAERS: 1US FAERS
159Gastrointestinal candidiasisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
160GliomaFAERS: 1US FAERS
161Graft versus host disease in gastrointestinal tractFAERS: 1US FAERS
162Graft versus host disease in skinFAERS: 1US FAERS
163Grip strength decreasedFAERS: 1US FAERS
164HemiparesisFAERS: 1OFFSIDES
US FAERS
165Hepatitis BFAERS: 1US FAERS
166HepatosplenomegalyFAERS: 1OFFSIDES
US FAERS
167HypokinesiaFAERS: 1US FAERS
168HypotensionFAERS: 1US FAERS
169HypothyroidismFAERS: 1US FAERS
170Immune thrombocytopenic purpuraFAERS: 1US FAERS
171Incorrect dose administeredFAERS: 1US FAERS
172Intestinal ObstructionFAERS: 1US FAERS
173LeukoencephalomyelitisFAERS: 1US FAERS
174LeukoencephalopathyFAERS: 1US FAERS
175Long QT SyndromeFAERS: 1US FAERS
176Lung infection pseudomonalFAERS: 1OFFSIDES
US FAERS
177Lymphocyte percentage increasedFAERS: 1US FAERS
178Medication ErrorFAERS: 1US FAERS
179Memory impairmentFAERS: 1US FAERS
180MeningitisFAERS: 1US FAERS
181Mental impairmentFAERS: 1US FAERS
182Myasthenia GravisFAERS: 1OFFSIDES
US FAERS
183Myasthenic SyndromeFAERS: 1US FAERS
184MyelitisFAERS: 1OFFSIDES
US FAERS
185MyelofibrosisFAERS: 1US FAERS
186MyositisFAERS: 1US FAERS
187Nasal inflammationFAERS: 1US FAERS
188NecrosisFAERS: 1US FAERS
189Neonatal disorderFAERS: 1US FAERS
190Neurological decompensationFAERS: 1OFFSIDES
US FAERS
191Oral candidiasisFAERS: 1US FAERS
192Oropharyngeal painFAERS: 1OFFSIDES
US FAERS
193OverdoseFAERS: 1US FAERS
194Paraneoplastic pemphigusFAERS: 1OFFSIDES
US FAERS
195Patent ductus arteriosusFAERS: 1US FAERS
196PhotophobiaFAERS: 1US FAERS
197Physical disabilityFAERS: 1US FAERS
198PolyneuropathyFAERS: 1OFFSIDES
US FAERS
199Polyomavirus-associated nephropathyFAERS: 1US FAERS
200Poverty of speechFAERS: 1US FAERS
201Product use issueFAERS: 1US FAERS
202Protein total decreasedFAERS: 1US FAERS
203PsoriasisFAERS: 1US FAERS
204Pulmonary EmbolismFAERS: 1US FAERS
205Pulmonary FibrosisFAERS: 1US FAERS
206QuadriparesisFAERS: 1US FAERS
207Rash erythematousFAERS: 1US FAERS
208Respiratory arrestFAERS: 1US FAERS
209RhinitisFAERS: 1US FAERS
210Skin reactionFAERS: 1US FAERS
211Squamous cell carcinoma of skinFAERS: 1OFFSIDES
US FAERS
212Subacute hepatic failureFAERS: 1US FAERS
213SyncopeFAERS: 1US FAERS
214Therapy cessationFAERS: 1US FAERS
215Therapy non-responderFAERS: 1OFFSIDES
US FAERS
216Toxic leukoencephalopathyFAERS: 1US FAERS
217Toxicity to various agentsFAERS: 1US FAERS
218Toxicologic test abnormalFAERS: 1US FAERS
219Troponin increasedFAERS: 1US FAERS
220TuberculosisFAERS: 1US FAERS
221Unresponsive to verbal stimuliFAERS: 1US FAERS
222Visual disturbanceFAERS: 1US FAERS
223Weight decreasedFAERS: 1US FAERS
224West Nile viral infectionFAERS: 1OFFSIDES
US FAERS
225nervous system disorderFAERS: 1US FAERS
226Abdominal tendernessOFFSIDES
227Acid fast bacilli infectionOFFSIDES
228Acquired pyloric stenosisOFFSIDES
229Acute bronchitisOFFSIDES
230Acute graft versus host disease in intestineOFFSIDES
231Acute graft versus host disease in liverOFFSIDES
232Acute kidney injuryCanada Vigilance: 1Canada Vigilance
233Acute sinusitisOFFSIDES
234AdenocarcinomaOFFSIDES
235Adenoviral hepatitisOFFSIDES
236Alanine aminotransferase abnormalOFFSIDES
237Aldolase increasedOFFSIDES
238AlkalosisCanada Vigilance: 1Canada Vigilance
239Altered state of consciousnessOFFSIDES
240Amylase increasedCanada Vigilance: 1Canada Vigilance
241Anal FistulaOFFSIDES
242Anal abscessOFFSIDES
243Anti-GAD antibodyOFFSIDES
244Anti-GAD antibody positiveOFFSIDES
245Anti-erythrocyte antibody positiveOFFSIDES
246Anti-platelet antibody positiveOFFSIDES
247Antithrombin III decreasedOFFSIDES
248Aortic valve calcificationOFFSIDES
249ApathyOFFSIDES
250Aphthous StomatitisOFFSIDES
251Aspartate aminotransferase abnormalOFFSIDES
252AspergillomaOFFSIDES
253AspergillosisOFFSIDES
254AutomatismOFFSIDES
255Axonal neuropathyOFFSIDES
256B-cell lymphoma recurrentOFFSIDES
257B-cell lymphoma stage IVOFFSIDES
258BK virus infectionOFFSIDES
259Back PainCanada Vigilance: 1Canada Vigilance
260Bacteria blood identifiedOFFSIDES
261Bacterial sepsisOFFSIDES
262Bacterial test positiveOFFSIDES
263Beta 2 microglobulin increasedOFFSIDES
264Biopsy bone marrow abnormalOFFSIDES
265Bladder spasmOFFSIDES
266BlepharospasmOFFSIDES
267Blood bilirubin unconjugated increasedOFFSIDES
268Blood blisterOFFSIDES
269Blood count abnormalOFFSIDES
270Blood fibrinogen increasedOFFSIDES
271Blood fibrinogenOFFSIDES
272Blood glucose abnormalOFFSIDES
273Blood immunoglobulin G decreasedOFFSIDES
274Blood stem cell transplant failureOFFSIDES
275Blood uric acidOFFSIDES
276Body temperature fluctuationOFFSIDES
277Bone marrow toxicityOFFSIDES
278Bone marrow transplant rejectionOFFSIDES
279Brain AbscessOFFSIDES
280Brain natriuretic peptide increasedOFFSIDES
281Bronchial ObstructionOFFSIDES
282Bronchoalveolar LavageOFFSIDES
283Bronchoalveolar lavage abnormalOFFSIDES
284CYTOMEGALOVIRUS ANTIGENOFFSIDES
285Candida pneumoniaOFFSIDES
286Candida sepsisOFFSIDES
287Capillary Leak SyndromeOFFSIDES
288Cardiac TamponadeOFFSIDES
289Cardiac neoplasm unspecifiedOFFSIDES
290CardiotoxicityOFFSIDES
291Cardiovascular insufficiencyOFFSIDES
292Catheter related complicationOFFSIDES
293Catheter related infectionOFFSIDES
294Cavernous Sinus ThrombosisOFFSIDES
295CellulitisOFFSIDES
296ChimerismOFFSIDES
297ChylothoraxOFFSIDES
298Citrobacter sepsisOFFSIDES
299Complex partial seizuresOFFSIDES
300Complications of bone marrow transplantOFFSIDES
301Complications of transplant surgeryOFFSIDES
302Cord blood transplant therapyOFFSIDES
303Corneal epithelium defectOFFSIDES
304Coronary artery dilatationOFFSIDES
305Coronary artery insufficiencyOFFSIDES
306CryptosporidiosisOFFSIDES
307Cutaneous CandidiasisOFFSIDES
308Cystitis viralOFFSIDES
309Cytarabine syndromeOFFSIDES
310Cytogenetic analysis abnormalOFFSIDES
311Cytokine Release SyndromeOFFSIDES
312Cytokine stormOFFSIDES
313Cytomegalovirus antibody positiveOFFSIDES
314Cytomegalovirus chorioretinitisOFFSIDES
315Cytomegalovirus enterocolitisOFFSIDES
316Cytomegalovirus gastroenteritisOFFSIDES
317Cytomegalovirus gastrointestinal infectionOFFSIDES
318Cytomegalovirus test positiveOFFSIDES
319Cytomegalovirus testOFFSIDES
320Dacryostenosis acquiredOFFSIDES
321Delayed engraftmentOFFSIDES
322Denervation atrophyOFFSIDES
323Device ineffectiveOFFSIDES
324Device related infectionOFFSIDES
325DiarrheaOFFSIDES
326Diffuse Large B-Cell LymphomaOFFSIDES
327Diffuse alveolar damageOFFSIDES
328Diffuse large B-cell lymphoma recurrentOFFSIDES
329Disease complicationOFFSIDES
330Disease recurrenceOFFSIDES
331Drug specific antibody absentOFFSIDES
332Drug toxicityOFFSIDES
333Ejection Fraction DecreasedOFFSIDES
334Electrocardiogram T wave biphasicOFFSIDES
335Embolic cerebral infarctionOFFSIDES
336Endothelial dysfunctionOFFSIDES
337Enterobacter sepsisOFFSIDES
338Enterococcal infectionOFFSIDES
339Enterococcal sepsisOFFSIDES
340Enterocolitis viralOFFSIDES
341EnterocolitisOFFSIDES
342Eosinophil percentage increasedOFFSIDES
343Eosinophilic myocarditisOFFSIDES
344Epidural AbscessOFFSIDES
345Epstein-Barr virus serology positiveOFFSIDES
346ErysipelasOFFSIDES
347Evans syndromeOFFSIDES
348Familial Mediterranean FeverOFFSIDES
349Febrile bone marrow aplasiaOFFSIDES
350Febrile infectionOFFSIDES
351Focal Nodular HyperplasiaOFFSIDES
352Fungus serology test positiveOFFSIDES
353Fungus stool identifiedOFFSIDES
354Gallop rhythm presentOFFSIDES
355Gastroenteritis norovirusOFFSIDES
356Gastrointestinal hypermotilityOFFSIDES
357Gastrointestinal infectionOFFSIDES
358Gastrointestinal toxicityOFFSIDES
359GliosisOFFSIDES
360GoutCanada Vigilance: 1Canada Vigilance
361Graft versus host disease in intestineOFFSIDES
362Graft versus host disease in liverOFFSIDES
363Graft versus host disease in lungOFFSIDES
364Granulocytes abnormalOFFSIDES
365Granulocytes maturation arrestOFFSIDES
366HaematotoxicityOFFSIDES
367Haptoglobin DecreasedOFFSIDES
368HemothoraxOFFSIDES
369Hepaplastin decreasedOFFSIDES
370Hepatic infection bacterialOFFSIDES
371Hepatic infection fungalOFFSIDES
372Hepatic vein occlusionOFFSIDES
373Hepatitis AOFFSIDES
374Hepatitis B antigen positiveOFFSIDES
375Hepatitis B positiveOFFSIDES
376Hepatitis C antibody positiveOFFSIDES
377Hepatitis C virus testOFFSIDES
378HepatitisOFFSIDES
379Human herpes virus 6 serology positiveOFFSIDES
380Human polyomavirus infectionOFFSIDES
381HydrothoraxOFFSIDES
382Hyperviscosity syndromeOFFSIDES
383Idiopathic pneumonia syndromeOFFSIDES
384Idiosyncratic drug reactionOFFSIDES
385Immune agglutininsOFFSIDES
386Immunodeficiency congenitalOFFSIDES
387Immunology test abnormalOFFSIDES
388ImmunosuppressionOFFSIDES
389Infection in an immunocompromised hostOFFSIDES
390Infective spondylitisOFFSIDES
391Injection Site ReactionCanada Vigilance: 1Canada Vigilance
392Intestinal adenocarcinomaOFFSIDES
393Intravascular papillary endothelial hyperplasiaOFFSIDES
394Kidney FailureOFFSIDES
395Kidney NeoplasmOFFSIDES
396Klebsiella sepsisOFFSIDES
397Labile blood pressureOFFSIDES
398Large cell carcinoma of the respiratory tract stage unspecifiedOFFSIDES
399LegionellaOFFSIDES
400Leriche SyndromeOFFSIDES
401Leukopenia neonatalOFFSIDES
402Lichen PlanusOFFSIDES
403Lower respiratory tract infection viralOFFSIDES
404Lung consolidationOFFSIDES
405Lymphadenitis viralOFFSIDES
406Lymphocytic infiltrationOFFSIDES
407LymphocytosisOFFSIDES
408LymphohistiocytosisOFFSIDES
409Lymphoma transformationOFFSIDES
410LymphomaOFFSIDES
411Mantle cell lymphomaOFFSIDES
412Mechanical ventilationOFFSIDES
413Megakaryocytes increasedOFFSIDES
414Meningitis enterococcalOFFSIDES
415Miller Fisher SyndromeOFFSIDES
416Molluscum ContagiosumOFFSIDES
417MononeuritisOFFSIDES
418Mouth BreathingOFFSIDES
419MucormycosisOFFSIDES
420Mycobacterium chelonei infectionOFFSIDES
421MyelodysplasiaOFFSIDES
422Myeloma recurrenceOFFSIDES
423Myocardial fibrosisOFFSIDES
424NeuralgiaCanada Vigilance: 1Canada Vigilance
425Neuroblastoma recurrentOFFSIDES
426NeuroblastomaOFFSIDES
427NeurocysticercosisOFFSIDES
428Neutropenic sepsisOFFSIDES
429NocturiaCanada Vigilance: 1Canada Vigilance
430Ocular ToxicityOFFSIDES
431OphthalmoplegiaOFFSIDES
432Optic AtrophyOFFSIDES
433Optic Disc EdemaOFFSIDES
434Oral mucosal exfoliationOFFSIDES
435OrthopneaOFFSIDES
436PO2 decreasedOFFSIDES
437PROTHROMBIN TIMEOFFSIDES
438Palmar erythemaOFFSIDES
439PancreatitisCanada Vigilance: 1Canada Vigilance
440ParotitisOFFSIDES
441Pathogen resistanceOFFSIDES
442PemphigusOFFSIDES
443Pericardial effusionOFFSIDES
444PericarditisOFFSIDES
445PlasmacytomaOFFSIDES
446Platelet TransfusionOFFSIDES
447PleocytosisOFFSIDES
448Pneumococcal sepsisOFFSIDES
449Pneumocystis jiroveci pneumoniaOFFSIDES
450Pneumonia herpes viralOFFSIDES
451Porphyria non-acuteOFFSIDES
452Post procedural sepsisOFFSIDES
453Product use in unapproved indicationCanada Vigilance: 1Canada Vigilance
454Prothrombin time ratio decreasedOFFSIDES
455Pseudomonal sepsisOFFSIDES
456Pulmonary sepsisOFFSIDES
457QuadriplegiaOFFSIDES
458RalesOFFSIDES
459Red blood cell schistocytes presentOFFSIDES
460Relapsing FeverOFFSIDES
461Reticulocyte count decreasedOFFSIDES
462ReticulocytopeniaOFFSIDES
463Retinal VasculitisOFFSIDES
464Rhinovirus infectionOFFSIDES
465Right ventricular systolic pressure increasedOFFSIDES
466Rotavirus test positiveOFFSIDES
467SalmonellaOFFSIDES
468SarcoidosisOFFSIDES
469SigmoiditisOFFSIDES
470Sinus headacheOFFSIDES
471Sinusitis aspergillusOFFSIDES
472Skin ErosionOFFSIDES
473Skin toxicityOFFSIDES
474Skull X-ray abnormalOFFSIDES
475Soft tissue necrosisOFFSIDES
476Splenic abscessOFFSIDES
477Stenotrophomonas infectionOFFSIDES
478Stenotrophomonas sepsisOFFSIDES
479Steroid withdrawal syndromeOFFSIDES
480Stevens-Johnson SyndromeCanada Vigilance: 1Canada Vigilance
481Sudden deathOFFSIDES
482Systemic mycosisOFFSIDES
483T-Cell LymphomaOFFSIDES
484Therapeutic product ineffectiveOFFSIDES
485Thoracic cavity drainageOFFSIDES
486Thrombotic strokeOFFSIDES
487TonsillitisOFFSIDES
488ToxoplasmosisOFFSIDES
489Trichosporon infectionOFFSIDES
490Trigeminal Nerve DisorderOFFSIDES
491Tuberculosis test positiveOFFSIDES
492Upper respiratory tract infection bacterialOFFSIDES
493Urinary tract infection pseudomonalOFFSIDES
494Venoocclusive diseaseOFFSIDES
495Viral vasculitisOFFSIDES
496Virus culture positiveOFFSIDES
497Virus serology test positiveOFFSIDES
498Virus urine test positiveOFFSIDES
499Vulval cancer recurrentOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120330

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.